Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Novel vasoprotectants in AtheroGenics' pipeline

April 5, 1996

PB-005 slated to enter phase II

April 5, 1996

Baxter to distribute coronary bypass graft

April 5, 1996

Cypros synthesizes adenosine deaminase inhibitors

April 5, 1996

New potassium channel openers from Nippon Kayaku

April 5, 1996

Genentech claims vitronectin antagonists

April 5, 1996

Vitronectin receptor antagonist revealed by SmithKline Beecham

April 5, 1996

Class III antiarrhythmics from Mitsui Toatsu

March 15, 1996

Kirin to codevelop antiischemic drug candidate

March 15, 1996

Potassium channel openers from Nippon Kayaku

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...